CapsoVision Inc. Common Stock
Financials
Valuation Metrics
CapsoVision Inc. Common Stock's Market Cap is $336M. At end of 2025 it was $501M. Ranked #2871 of 3,118 in US market (top 92%), #1285 of 1,474 on NASDAQ (top 87%), #228 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 86%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $336M | US#2,871/3,118 Sec#228/265 |
| Revenue | $14M | US#2,793/3,118 Sec#164/265 |
| Net Income | $-30M | US—/3,118 Sec—/265 |
| Total Assets | $19M | US#3,081/3,118 Sec#264/265 |
| Net Assets | $13M | US#2,891/3,118 Sec#234/265 |
| Employees | 99 | US#2,619/3,118 Sec#179/265 |
| Value | ||
| P/B | 25.54x | US#2,829/3,118 Sec#222/265 |
| P/S | 24.21x | US#2,870/3,118 Sec#150/265 |
| FCF Yield | -8.29% | US—/3,118 Sec—/265 |
| Profitability | ||
| Op. Margin | -158.64% | US#2,733/3,118 Sec#130/265 |
| Revenue Growth | 10.99% | US#1,170/3,118 Sec#93/265 |
| Financial Health | ||
| Debt Ratio | 41.04% | US#468/3,118 Sec#128/265 |
| Total Debt | $687000.00 | US#2,972/3,118 Sec#245/265 |
| FCF | $-28M | US#2,450/3,118 Sec#100/265 |
| Cash | $9M | US#2,970/3,118 Sec#261/265 |
| Current Ratio | 3.35x | US#677/3,118 Sec#176/265 |
| Dividend | ||
| Div. Yield | 0.00% | US#1,741/3,118 Sec#27/265 |
| Performance | ||
| 1Y Return | 37.91% | US#559/3,118 Sec#77/265 |
| 1M Return | 9.08% | US#1,179/3,118 Sec#72/265 |
| From 52W High | -56.21% | US#2,748/3,118 Sec#214/265 |
| 1Y MDD | -67.82% | US#2,893/3,118 Sec#231/265 |
| Trading | ||
| Volume | 95,852 shares | US#3,023/3,118 Sec#262/265 |
| Trading Value | $652752.00 | US#3,076/3,118 Sec#263/265 |
| Per Share | ||
| EPS | $-0.60 | US—/3,118 Sec—/265 |
| BPS | $0.26 | US#2,775/3,118 Sec#225/265 |
Company Info
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.